Bionano Genomics Inc (BNGO)
0.2559
-0.02
(-7.58%)
USD |
NASDAQ |
Nov 14, 16:00
0.255
0.00 (0.00%)
Pre-Market: 08:55
Bionano Genomics Cash from Investing (Quarterly): 28.63M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 28.63M |
| March 31, 2024 | 47.59M |
| December 31, 2023 | -55.37M |
| September 30, 2023 | 33.43M |
| June 30, 2023 | 29.58M |
| March 31, 2023 | 16.53M |
| December 31, 2022 | 11.61M |
| September 30, 2022 | 7.953M |
| June 30, 2022 | 31.24M |
| March 31, 2022 | 31.96M |
| December 31, 2021 | -92.51M |
| September 30, 2021 | -185.60M |
| June 30, 2021 | 0.074M |
| March 31, 2021 | -0.024M |
| December 31, 2020 | 0.00 |
| Date | Value |
|---|---|
| September 30, 2020 | -2.45M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | -0.0231M |
| September 30, 2019 | -0.008M |
| June 30, 2019 | -0.03M |
| March 31, 2019 | |
| December 31, 2018 | -0.0118M |
| September 30, 2018 | -0.1305M |
| June 30, 2018 | -0.1776M |
| March 31, 2018 | -0.0118M |
| December 31, 2017 | -0.2818M |
| September 30, 2017 | -0.2741M |
| June 30, 2017 | -0.3904M |
| March 31, 2017 | -0.0715M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-185.60M
Minimum
Sep 2021
47.59M
Maximum
Mar 2024
-5.126M
Average
0.074M
Median
Jun 2021
Cash from Investing (Quarterly) Benchmarks
| Revvity Inc | 690.18M |
| Bruker Corp | -67.60M |
| Azenta Inc | 201.62M |
| Harvard Bioscience Inc | -1.111M |
| Akoya Biosciences Inc | 9.054M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -20.98M |
| Cash from Financing (Quarterly) | -1.978M |
| Free Cash Flow | -106.10M |
| Free Cash Flow Per Share (Quarterly) | -3.115 |
| Free Cash Flow to Equity (Quarterly) | -11.33M |
| Free Cash Flow to Firm (Quarterly) | -21.06M |
| Free Cash Flow Yield | -1.23K% |